Mundipharma
is an England-based pharmaceutical company that accelerates the development of medicines for patients and healthcare providers... Read moreMundipharma
is an England-based pharmaceutical company that accelerates the development of medicines for patients and healthcare providers... Read more
News
Apr 27, 2026
FiercePharma
Mundipharma: <a href="https://www.fiercepharma.com/pharma/trial-win-sets-mundipharma-cormedix-expansion-rezzayo" hreflang="en">Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win</a>
Apr 27, 2026
FinanzNachrichten
Mundipharma: Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ?REZZAYO (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients
Nov 03, 2025
Korea Biomedical Review
Mundipharma: Samjin and Mundipharma will co-supply 2 wound-care dressings to Korean hospitals
Oct 10, 2025
FinanzNachrichten
Mundipharma: Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO (rezafungin)
Apr 08, 2025
Openpr
Mundipharma: Future of Cancer Pain Market Size, Share & Trends 2024-2031 | Most Leading Companies - CK Life Sciences (WEX Pharmaceuticals Inc), Mundipharma International., Orexo AB
Feb 20, 2025
Business Wire
Press Release: Mundipharma : New global guideline published on managing fungal infections caused by Candida
Feb 06, 2025
Openpr
Mundipharma: Cancer Pain Market is expected to reach US$ 11.02 billion by 2031, growing at a CAGR of 5.6% - Mundipharma International., Orexo AB, DAIICHI SANKYO COMPANY.
Sep 16, 2024
Openpr
Mundipharma: Rapid Growth in Global Inhalable Drugs Market Overall Study Report 2024-2031 |GSK plc., Mundipharma International., Boehringer Ingelheim International GmbH., Cipla Inc.
Jul 03, 2024
Korea Biomedical Review
Mundipharma: Samjin Pharm and Mundipharma Korea to co-promote Norspan patch
Apr 25, 2024
Pharamceutical Technology
Mundipharma: Mundipharma to acquire rezafungin assets from Cidara Therapeutics
Mundipharma Competitors
1
2
3
4
5
6
7
8
9
10